HLB cuts HLB Biostep stake to 17.61% from 19.91% after off — market sale
HLB cut its stake in HLB Biostep to 3,070,366 shares, or 17.61%, from 3,570,990 shares, or 19.91%. The disclosure dated the change to July 14, 2026, citing an off-market sale by related parties. Two affiliates sold 250,312 convertible bond rights each off-market to HLB Biostep at KRW 7,990. Disclaimer: This news brief